Patents by Inventor Nicola Camp

Nicola Camp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Depression gene
    Patent number: 7544475
    Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human depression predisposing gene, specifically the apoptotic protease activating factor 1 (APAF1) gene, some mutant alleles of which cause susceptibility to depression. More specifically, the invention relates to germline mutations in the APAF1 gene and their use in the diagnosis of predisposition to depression. The invention also relates to the prophylaxis and/or therapy of depression associated with a mutation in the APAF1 gene. The invention further relates to the screening of drugs for depression therapy. Finally, the invention relates to the screening of the APAF1 gene for mutations/alterations, which are useful for diagnosing the predisposition to depression.
    Type: Grant
    Filed: May 17, 2007
    Date of Patent: June 9, 2009
    Assignee: IHC Health Services, Inc.
    Inventors: Donna Shattuck, Deanna Russell, Victor Abkevich, Chris Neff, Lisa Cannon-Albright, Nicola Camp
  • DEPRESSION GENE
    Publication number: 20080160519
    Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human depression predisposing gene, specifically the apoptotic protease activating factor 1 (APAF1) gene, some mutant alleles of which cause susceptibility to depression. More specifically, the invention relates to germline mutations in the APAF1 gene and their use in the diagnosis of predisposition to depression. The invention also relates to the prophylaxis and/or therapy of depression associated with a mutation in the APAF1 gene. The invention further relates to the screening of drugs for depression therapy. Finally, the invention relates to the screening of the APAF1 gene for mutations/alterations, which are useful for diagnosing the predisposition to depression.
    Type: Application
    Filed: May 17, 2007
    Publication date: July 3, 2008
    Applicant: Intermountain Health Care, Inc.
    Inventors: Donna Shattuck, Deanna Russell, Victor Abkevich, Chris Neff, Lisa Cannon-Albright, Nicola Camp
  • Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype
    Publication number: 20050282198
    Abstract: Methods and kits for determining whether a subject has or is predisposed to developing a disease which is associated with IL-1 polymorphisms and assays for identifying therapeutics for treating and/or preventing the development of these diseases are provided.
    Type: Application
    Filed: May 3, 2005
    Publication date: December 22, 2005
    Inventors: Gordon Duff, Angela Cox, Nicola Camp, Franceso diGiovine, Kenneth Kornman, Leon Wilkins, Hongmin Chen, John Rogus